All News

A Senate committee passed a measure to advance the SAFER Banking Act which will now go to a full vote in the chamber and potentially open doors in the cannabis industry.

Veterans took center stage at Cannabis Science Conference Fall to kick off the medical track with an important film screening followed by a panel discussion.

Our sister publication, LCGC, covered a presentation from Scott Churchill, Vice President of Scientific Development for MCR Labs, in the Analytical Track of the Cannabis Science Conference Fall 2023.

An NCAA committee has made a formal recommendation to remove cannabis from their banned substances list for college athletes.

Our sister publication, LCGC, covered a presentation from Zacariah Hildenbrand, PhD, in the Analytical Track of the Cannabis Science Conference Fall 2023.

Our sister publication, LCGC, covered Christopher Hudalla of ProVerde Laboratories Inc. talk from our Cannabis Science Conference Fall 2023 show where he discussed how using liquid chromatography–mass spectrometry (LC–MS) could be used to quantify specific classes of PPL constituents that can help streamline cannabis extraction.

Here, Mike Verret from Mother Earth Wellness explains historical and cultural shifts in the perception of cannabis.

Our sister publication, Pharmacy Times, recently published an article covering indigenous use of ayahuasca and DEA restrictions.

Katherine Golden, a registered nurse and CEO, executive director, and founder of Leaf411, shared with our sister brand, Cannabis Patient Care, how cannabis can be a powerful tool as an alternative or adjunct treatment for someone who is struggling with acute or chronic pain.

If passed, the possession, use, and cultivation of certain natural psychedelic substances would be decriminalized starting in 2025.

In a recent article, our sister publication, Pharmacy Times, reports on how the opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.

Joining other Caribbean nations such as Jamaica and Antigua, the Commonwealth of the Bahamas is re-examining its cannabis laws.

Rhode Island cannabis cultivator, Fire Ganja, may lose their license to grow cannabis due to unregistered plants and ownership issues.

In a recent vote, New York regulators agreed to allow medical cannabis operators to apply for adult-use retail licenses.

A tribe in western North Carolina recently approved recreational cannabis, resulting in proposed federal legislation in response.

National Geographic recently looked at potential locations around the world where cannabis tourism could flourish.

California looks to legalize cannabis cafes with a new bill that is heading towards Governor Gavin Newsom’s desk.

More cannabis companies are employing AI to save time and enhance user shopping experience.

A recent study in Molecular Psychiatry suggests CBD use during pregnancy may harm fetal brain development, posing a cognitive risk.

In a recent article, our sister publication, Drug Topics, discusses how pharmacists need to step up to educate and counsel customers on safe use of cannabis.

Separate efforts to remove the medical cannabis program and legalize recreational cannabis in South Dakota are proposed to appear on the 2024 ballot.

Let’s meet CSC Fall speaker Adam Jacques, a world-renowned expert with more than 20 years’ experience cultivating various unique strains of cannabis.

Let’s meet CSC Fall speaker Frankie Claunch, a microbiologist and Microbial/Environmental consultant for PuEr Lab, LLC.

What is ethalfluralin and what does this herbicide have to do with growing hemp?

Canadian cannabis producer, MediPharm Labs, has exported oil which contains CBD and THC to the US to be used in a clinical trial.

On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.

A recent study sought to examine the occurrence of cannabis use disorder in patients and recreational users, specifically in a state with legal cannabis access.

In a recent article, our sister publication, Nutritional Outlook, delves into the controversial delta-8 THC hemp cannabinoid and why it is such a hot topic right now.

The recently approved legislation creates new opportunities for possession and cultivation.

Our sister publication, Nutritional Outlook, recently discussed Apex Compliance's latest new software detects risky marketing terms and phrases and suggests lower-risk alternatives.